← Back
$APUS All transactions

Apimeds Pharmaceuticals US, Inc.

A

$ Value

$0

Shares

10,000

Price

$0

Filed

Nov 13

Insider

Name

Yoon Hankil

Title

CIK

0002041300

Roles

Director

Transaction Details

Transaction Date

2025-11-11

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,000

Footnotes

The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan.

Filing Info

Accession No.

0002041300-25-000003

Form Type

4

Issuer CIK

0001894525

Yoon Hankil's History

Date Ticker Type Value
2025-11-11 APUS A $0
2025-10-15 APUS A $0
2025-05-16 APUS A $0

Other Insiders at APUS (90d)

No other insider activity at this issuer in the last 90 days.